Effect of sacubitril-valsartan on the incidence of atrial fibrillation: A meta-analysis.
Zoya MohammadJavaria AhmadAli SultanAshritha PenagaluriDaniel P MorinPaari DominicPublished in: Journal of cardiovascular electrophysiology (2023)
Although sacubitril/valsartan reduces mortality compared to ACEIs/ARBs in HF patients, they do not reduce AF risk compared to these drugs.
Keyphrases
- ejection fraction
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- risk factors
- chronic kidney disease
- heart failure
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- percutaneous coronary intervention
- left atrial
- catheter ablation
- left atrial appendage
- oral anticoagulants
- coronary artery disease
- left ventricular
- direct oral anticoagulants
- venous thromboembolism